TOPICAL MITOMYCIN-C 0.01% VERSUS DEXAMETHAZONE PHOSPHATE 0.1% IN REFRACTORY VERNAL KERATOCONJUNCTVITIS

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

SAMAVATI M.; BAZAZI N.

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: BINA Year:2006 | Volume:11 | Issue:4 (45) Page(s): 457-463

Download Full-Text

Persian Verion

View:

883

Download:

Cites:

Information Journal Paper

Title

TOPICAL MITOMYCIN-C 0.01% VERSUS DEXAMETHAZONE PHOSPHATE 0.1% IN REFRACTORY VERNAL KERATOCONJUNCTVITIS

Author(s)

SAMAVATI M. | BAZAZI N. | Issue Writer Certificate

Keywords

VERNAL KERATOCONJUNCTIVITISQ3

ALLERGIC CONJUNCTIVITISQ3

MITOMYCIN-CQ3

DEXAMETHAZONE PHOSPHATEQ3

Abstract

Purpose: To compare the efficacy and safety of topical MITOMYCIN-C 0.01% versus DEXAMETHAZONE PHOSPHATE 0.1% in patients with refractory VERNAL KERATOCONJUNCTIVITIS (VKC).Methods: In this double blind randomized clinical trial, patients with refractory VKC were randomly assigned to treatment with topical MITOMYCIN-C 0.01% eye drops (N=27) or DEXAMETHAZONE PHOSPHATE 0.1% (N=27), four times daily for 20 days. Symptoms including foreign body sensation, tearing, itching, mucous discharge and signs including conjunctival hyperemia, conjunctival giant papillae, limbal hypertrophy, and Trantas dots, were compared before after treatments between the two groups.Results: There was a statistically significant decrease in signs and symptoms in the MITOMYCIN-C group at the end of 20 days of treatment such that two cases (7.4%) of the mitomycin group and 26 cases (96%) of the dexamethazone group required another medication. (P=0.000).Conclusion: Short-term low dose topical MITOMYCIN-C may be considered for acute exacerbations of severe VKC.

Cites

No record.

References

Cite

APA: Copy

SAMAVATI, M., & BAZAZI, N.. (2006). TOPICAL MITOMYCIN-C 0.01% VERSUS DEXAMETHAZONE PHOSPHATE 0.1% IN REFRACTORY VERNAL KERATOCONJUNCTVITIS. BINA, 11(4 (45)), 457-463. SID. https://sid.ir/paper/42422/en

Vancouver: Copy

SAMAVATI M., BAZAZI N.. TOPICAL MITOMYCIN-C 0.01% VERSUS DEXAMETHAZONE PHOSPHATE 0.1% IN REFRACTORY VERNAL KERATOCONJUNCTVITIS. BINA[Internet]. 2006;11(4 (45)):457-463. Available from: https://sid.ir/paper/42422/en

IEEE: Copy

M. SAMAVATI, and N. BAZAZI, “TOPICAL MITOMYCIN-C 0.01% VERSUS DEXAMETHAZONE PHOSPHATE 0.1% IN REFRACTORY VERNAL KERATOCONJUNCTVITIS,” BINA, vol. 11, no. 4 (45), pp. 457–463, 2006, [Online]. Available: https://sid.ir/paper/42422/en

Related Journal Papers